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Our aim was to investigate whether the antioxidant quercetin protects against liver injury and ameliorates the systemic oxidative
stress in rats with common bile duct ligation. Secondary biliary cirrhosis was induced through 28 days of bile duct obstruction.
Animals received quercetin (Q) after 14 days of obstruction. Groups of control (CO) and cirrhotic (CBDL) animals received a
daily 50 mg/kg body weight i.p. injection of quercetin (CO + Q; CBDL + Q) or vehicle (CO; CBDL). Quercetin corrected the
reduction in superoxide dismutase (SOD), catalase CAT, and glutathione peroxidase GPx activities and prevented the increase
of thiobarbituric acid reactive substances (TBARS), aminotransferases, and alkaline phosphatase in cirrhotic animals. Quercetin
administration also corrected the reduced total nitrate concentration in the liver and prevented liver ﬁbrosis and necrosis. These
eﬀects suggest that quercetin might be a useful agent to preserve liver function and prevent systemic oxidative stress.
1.Introduction
Biliary cirrhosis is extrahepatic structure and function and
is a potential late complication resulting from prolonged
obstruction of extrahepatic biliary pathways. It occurs in
less than one tenth of patients with biliary cirrhosis, as
described previously [1]. This disease is accompanied by
diﬃcultyinbileeliminationduetothedestructionofhepatic
parenchyma and progressive ﬁbrosis [2].
The cytotoxicity of biliary acids is attributed to several
mechanisms, including its detergent properties, alterations
in intracellular Ca++ homeostasis, decreases in ATP, and
mitochondrial damage. It has been suggested that alterations
in antioxidant mechanisms occur with the pathogenesis
of cholestatic hepatic damage, resulting in an imbalance
of oxidative and antioxidative processes, which stimulates
lipoperoxidation and leads to injuries in several systems [3].
The concentration of bile acids increases in rats after bile
duct obstruction, which induces lipid peroxidation, and is
probably related to the stimulation of phagocytic activity in
polymorphonuclear phagocytes and inﬂammatory cells [4].
Many experimental studies have reported beneﬁcial
eﬀects of antioxidants in cholestasis [5–7]. Intraperi-
toneal administration of resveratrol maintained antioxidant
defenses and reduced liver oxidative damage, ductular prolif-
eration, and ﬁbrosis in bile duct ligated rats [8].
Flavonoids are phenolic phytochemicals that represent
essential constituents of the nonenergetic part of the human
diet. They are thought to promote optimal health, partly via
their antioxidant eﬀects in protecting cellular components
against reactive oxygen species (ROS) [9, 10]. Some com-
pounds that have been studied as possible protectors against2 ISRN Gastroenterology
liver cirrhosis are known for their anti-inﬂammatory and
antioxidant properties. Plants contain numerous polyphe-
nols, which have been shown to reduce inﬂammation and
thereby increase resistance to disease [11]. Quercetin (Q), a
polyphenolic ﬂavonoid compound present in large amounts
in vegetables, fruits, and tea, exhibits therapeutic potential,
including hepatoprotection and the inhibition of liver ﬁbro-
sis, against many diseases [10, 12, 13]. It contains a number
of phenolic hydroxyl groups that have strong antioxidant
activity [14, 15]. The average intake varies among people
by country but is approximately 23mg/day; quercetin is
predominant at 16mg/day [14].
By increasing the endogenous antioxidant defenses,
ﬂavonoids can modulate the redox state of organisms. The
major endogenous antioxidant systems include superoxide
dismutase (SOD), catalase (CAT), glutathione reductase
(GR), and glutathione peroxidase (GPx), which are essential
for the detoxiﬁcation of lipid peroxides [12, 16].
In cirrhosis patients, the use of blood markers to deter-
mine the oxidative stress level and the eﬃciency of the
antioxidant used may qualify the diagnosis and allow for a
better survival curve [17]. The purpose of our study was
to ascertain whether treatment with quercetin ameliorates
the systemic oxidative stress in rats with common bile duct
obstruction.
2.MaterialsandMethods
2.1. Animals and Experimental Procedures. All studies were
performed in accordance with the Guiding Principles for
Research Involving Animals at HCPA [18]. Male Wistar rats
were obtained from the CREAL (Centro de Reproduc ¸˜ ao
Animal) of the UFRGS, Porto Alegre, Brazil. They were
housed in temperature- and humidity-controlled rooms
with a 12-hr light-dark cycle and with standard rat chow
and free access to tap water. Secondary biliary cirrhosis
was induced in animals weighing approximately 250g by
double ligation and division of the common bile duct. The
animals were sacriﬁced after 28 days of obstruction, a time
at which there is complete development of both cholestasis
and ﬁbrosis and clear establishment of liver biochemical
changes[3].Controlanimalsweresham-operated.Quercetin
(Sigma)wasresuspendedimmediatelybeforeadministration
in a 2% tween aqueous solution. Treatment was initiated
after 14 days of obstruction. Groups of control (CO) and
cirrhotic (CBDL) animals received a daily 50mg/kg body i.p.
injection of quercetin (CO + Q, n = 7; CBDL + Q, n = 7) or
vehicle(CO,n =7;CBDL,n =7).Theratswereanaesthetized
with 2% xylazine hydrochloride (50mg/kg) and ketamine
hydrochloride (100mg/kg) administered by i.p. injection.
Venous blood was collected in two aliquots from the orbital
sinus [19] for the systemic oxidative stress analyses and
for analysis of aspartate aminotransferase (AST), alanine
aminotransferase (ALT), and alkaline phosphatase (ALP)
activities (performed by the Laboratory of Pathology at
HCPA-RS, Brazil). The livers were excised, weighed, and
divided for histological and biochemical analyses.
2.2. Biochemical Analysis. Plasma was collected from the
remaining sample by centrifugation at 2195×gf o r5 m i n
at 4◦C. Erythrocytes were washed with cold saline three
times. Hemoglobin content of blood was estimated by
the cyanmethemoglobin method described by Drabkin and
Austin[20],andtheamountofaldehydicproductsgenerated
by lipid peroxidation in erythrocytes was quantiﬁed with a
thiobarbituric acid (TBA) reaction. The results were referred
to as TBARS [21]. SOD (EC 1.15.1.1) in erythrocytes was
assayed according to the protocol of Misra and Fridovich
[22]; CAT (EC 1.11.1.6) activity was determined by mea-
suring the exponential disappearance of H2O2 at 240nm
according to the protocol of Aebi [23]. Analysis of GPx
(EC 1.11.1.19) activity was carried out according to the
method of Flohe and Guntzler [24]. Protein concentration
was measured according to the method of Lowry et al. [25]
using serum bovine albumin as standard.
For histological studies, a piece of the liver was trimmed
a n dﬁ x e db yi m m e r s i o ni n1 0 %b u ﬀered formalin for 24hr.
The obtained blocks were dehydrated in a graded series of
ethanol,embeddedinparaﬃn,andstainedwithhematoxylin
and eosin or picros´ ırius, which mainly stains collagen ﬁbers
(performed by the Laboratory of Pathology at HCPA-RS,
Brazil).
Frozen liver from each rat was homogenized in ice-
cold phosphate buﬀer (KCl 140mmol/L and phosphate
20mmol/L, pH 7.4) and centrifuged at 14,000×g for 10min.
Nitric oxide production was measured indirectly using a
quantitative colorimetric assay based on the Griess reaction,
according to Granger et al. [26].
2.3. Statistical Analysis. Results were expressed as the mean
values ± SEM. The data were compared by analysis of
variance (ANOVA); when the analysis indicated a signiﬁcant
diﬀerence, the means were compared with the Student
Newman-Keuls test. Values were considered signiﬁcant at P
< 0.05.
3. Results
3.1. AST, ALT, and ALP. The cirrhotic group had higher
levels of AST, ALT, and ALP compared to the control group.
Treatment with quercetin signiﬁcantly reduced the higher
levels of aminotransferases and ALP induced by biliary
obstruction (Table 1).
3.2. Liver Histology. The histological analysis of liver tissue
from the animals in the control group (CO) showed normal
architecture of the parenchyma (Figures 1(a) and 1(b)). In
a n i m a l sw i t hC B D L ,t h e r ew e r eal o s so fn o r m a la r c h i t e c t u r e
and a presence of regenerative nodules, cellular necrosis,
(Figure 1(c)),andﬁbrosis(Figure 1(d)).Incontrast,necrosis
and ﬁbrosis were minimal in animals from the group treated
with quercetin (CBDL + Q) (Figures 1(e) and 1(f)).
3.3. Parameters of Lipid Peroxidation, Antioxidant Enzyme
Activities, and Total Nitrate Concentrations. The TBARS
concentration was signiﬁcantly increased in the CBDL rats,
whereas this increase was inhibited by quercetin treatment.ISRN Gastroenterology 3
Table 1: Eﬀects of biliary obstruction determined by hepatic integrity tests.
Parameters Experimental groups
CO CO + Q CBDL CBDL + Q
AST (U/L) 95.67 ± 10.34 66.44 ± 2.26 510.6 ± 46.78a 146.9 ± 23.44
ALT (U/L) 65.78 ± 9.02 38.44 ± 2.51 127.5 ± 13.03a 52.8 ± 9.36
FA (U/L) 156.00 ± 16.62 143.33 ± 9.23 386.8 ± 27.71a 218.9 ± 42.73
CO: control; CBDL: common bile duct ligation; CO + Q and CBDL + Q: animals received a daily 50mg/kg body i.p. injection of quercetin.
aSigniﬁcant diﬀerence between the CBDL group and groups CO, CO + Q, and CBDL + Q; P < 0.05.
(a) (b)
(c) (d)
(e) (f)
Figure 1: Photomicrographs of liver sections from rats (100x). Liver sections were stained with hematoxylin and eosin (a, c and e) or with
picros´ ırius (b, d and f). (a) and (b): control rats (CO), showing normal architecture of liver parenchyma. (c) and (d): untreated rats with
common bile duct obstruction (CBDL), showing regenerative nodules (arrow (c)) and ﬁbrosis (arrow (d)). (e) and (f): Biliary obstructed
rats treated with quercetin (CBDL + Q), showing the regeneration of liver parenchyma (arrow (e)) and light ﬁbrosis (arrow (f)).
Lipid peroxidation was not modiﬁed by quercetin in normal
rats (Table 2).
We measured SOD enzymatic activity in erythrocytes
and veriﬁed a reduction in enzymatic activity in the CBDL
group compared to the CO and CO + Q and to the cirrhotic
group treated with quercetin (CBDL + Q) (Table 2).
(1) IntheevaluationoftheantioxidantenzymesGPxand
CAT, both exhibited a signiﬁcant reduction in the
cirrhotic group CBDL. When animals were treated
with quercetin, signiﬁcantly increased enzyme activ-
ity, restoring values similar to those of the control
group (Table 2).4 ISRN Gastroenterology
Table 2:Eﬀectsofquercetin(Q)onlipidperoxidation,antioxidantenzymeactivities,andtotalnitratesondamageduetobiliaryobstruction.
Parameters Experimental groups
CO CO + Q CBDL + Q CBDL + Q
TBARS (nmol/mg Hb) 3.01 ± 0.22 2.46 ± 0.29 5.69 ± 0.23a 3.87 ± 0.06b
SOD (U-SOD/mg protein) 9.26 ± 0.55 8.26 ± 1.02 5.35 ± 0.53a 9.35 ± 0.46
CAT (pmol/mg protein) 0.1 ± 0.01 0.11 ± 0.01 0.05 ± 0.01a 0.09 ± 0.01
GPx (mmol/min/mg Hb) 3.45 ± 0.36 4.00 ± 0.61 2.15 ± 0.69a 4.63 ± 0.66
Nitrates (µmol/L) 125.6 ± 18.1 110.5 ± 9.12 64.99 ± 5.67a 92.65 ± 5.75
CO: control; CBDL: common bile duct ligation; CO + Q and CBDL + Q: animals received a daily 50mg/kg body i.p. injection of quercetin
Results represent the mean ± S.E.
aSigniﬁcant diﬀerence between the CBDL group and the CO, CO + Q, and CBDL + Q groups; P < 0.05.
bSigniﬁcant diﬀerence between the CBDL + Q group and the CO and CO + Q groups; P< 0.05.
Totallivernitrateconcentrationwassigniﬁcantlyreduced
in obstructed rats. Values were signiﬁcantly increased in
groups of quercetin-treated animals (Table 2).
4. Discussion
Biliary cirrhosis is a chronic and diﬀuse hepatic disease
that alters the intrahepatic or extrahepatic structure and the
function of the biliary tree [27]. CBDL is used as an animal
model of secondary biliary cirrhosis and, in four weeks,
establishes cirrhosis with progressive and fatal damages to
theliver.Thismodelsimulatesthehumandisease,generating
alterations from the inﬂammatory reaction caused by biliary
ebb and the consequent disorganization of the parenchyma
architecture, inﬂammatory and collagen depositions, and
ﬁbrosis formation [3].
Hepatic damage results in increased concentrations of
serum AST, ALT, and ALP. Animals that underwent common
bile duct ligation showed a signiﬁcant increase in serial
enzymes AST, ALT, and ALP, which are regarded as sensitive
markers of hepatic damage and indicators of parenchymal
and biliary tree injuries. Hepatic lesions and increases in
these serial enzymes were also reported in several studies on
bile duct obstruction [3, 5, 10].
Animals made cirrhotic by CBDL and treated with
the antioxidant quercetin experienced restoration of the
evaluated enzymes representing hepatic integrity. These
results demonstrate that the ﬂavonoid, due to its antioxidant
potential, had a hepatoprotective function. Peres et al. have
also reported quercetin treatment to reduce the high AST,
ALT, and ALP levels present in bile duct obstruction-induced
cirrhosis [6]a n dt oe ﬀectively protect the liver against
CCl4-induced hepatotoxicity [10]. In our study, CBDL was
accompanied by regenerative nodules, necrosis, and centers
of ﬁbrosis. The cirrhotic animals treated with quercetin
(CBDL + Q) exhibited this phenomenon to a lesser degree.
These ﬁndings are in accordance with other studies that used
quercetin or other antioxidant substances, such as rutin, N-
acetylcysteine, and vitamins E and C, all of which decreased
the severity of hepatic ﬁbrosis [3, 5, 10, 17, 28].
When we evaluated the levels of total nitrates in the
homogenized livers of the CBDL group, we observed a
signiﬁcant 52% reduction of these metabolites compared to
the CO group (Table 2). In the CBDL + Q group, reduction
of 26.4% was observed, suggesting that quercetin treatment
inhibited the reduction of the metabolites activity due to
an imbalance between vasoconstrictors and vasodilators.
In the CO group, vasoconstrictors, such as endotelin-1,
and vasodilators, such as nitric oxide (NO), are balanced
in the liver. However, in an injured liver, the balance of
these substances is lost. This imbalance characterizes the
endotheliopathy of the cirrhotic liver, which has increased
synthesis of endotelin-1. This phenomenon promotes vaso-
constriction and increased intrahepatic resistance to blood
ﬂow, which provides an explanation for the low quantity of
total nitrates present in this study [29]. Quercetin increases
total liver nitrates due to its potential for scavenging free
radicals, suggesting that it promotes increased circulation
through the hepatic parenchyma.
Oxidative stress is deﬁned as an imbalance between pro-
oxidants and antioxidants; ROS-induced lipid peroxidation
can occur either in overwhelmed scavenging systems (exces-
sive production of ROS) or in impaired antioxidant systems.
In cirrhotic animals, there is a considerable increase in
liver lipoperoxidation due to the formation of ROS. When
lipoperoxidation was evaluated, we observed an increase in
TBARS in the erythrocytes of the CBDL animals compared
to the CO rats. We suggest that the increase in this process
is related to the increase in oxidative stress, which has
already been shown in hepatic tissue by other studies [5, 6].
The increased oxidative stress in the CBDL model can be
explained by endotoxemia and increased biliary acids, which
canleadtoanimbalanceinthemitochondrialelectrontrans-
port chain and can subsequently favor increased production
of ROS [3, 30].
Afterquercetintreatment,animalsfromtheCBDLgroup
had TBARS values that were similar to those of the control
group, indicating the antioxidant potential of this ﬂavonoid.
The reduction of lipoperoxidation in the hepatic tissue of the
CBDL rats had already been demonstrated by the use of the
antioxidant quercetin in the CBDL model [5, 6, 13].
Due to its antioxidant action, quercetin seems to protect
the liver and ameliorate hepatic function; in a secondary
pathway, it diminishes bacterial translocation from the
gastrointestinal tract and, consequently, the severity of the
disease [31].
The SOD enzyme is the cell’s ﬁrst line of defense against
oxidative stress [32]. In the present study, we observed aISRN Gastroenterology 5
reduction in SOD and CAT enzyme activity in the erythro-
cytes of cirrhotic animals compared to the other groups.
Moreover, CBDL + Q animals maintained SOD enzyme
activity similar to the animals of the CO group. Similar
data were observed by Peres et al. in hepatic tissue treated
with the ﬂavonoid quercetin. These ﬁndings suggest that this
ﬂavonoid preserves SOD both in the hepatic tissue and in
the erythrocytes of these animals [6]. Furthermore, the data
reinforce the hypothesis that ﬂavonoids, including quercetin,
are potent sweepers of free radicals, such as hydroxyl radicals
and superoxide anions, because the use of ﬂavonoids results
in an SOD activity similar to that of the CO group. We
also observed a signiﬁcant reduction of CAT activity in the
erythrocytes from the cirrhotic group, possibly due to the
excessive generation of H2O2 from dismutation of superox-
ideradicalanions.Intheanimalstreatedwithquercetin,CAT
activity remained similar to that of the control group.
GPx activity was signiﬁcantly reduced in animals with
CBDL, possibly due to increased superoxide anions and
hydrogen peroxide, which presumably bind to the active site
of the enzyme. Additionally, rats with CBDL lacked vitamin
E, and selenium deﬁciency is known to cause depletion of
tissue GPx activity, which makes tissue more vulnerable
to oxidative damage [33]. The GPx enzyme is the primary
catalyticcellulardefensethatprotectscellsandtissuesagainst
lipid peroxidation. A reduction of GPx activity was observed
in homogenized liver and lung from cirrhotic animals, and
this reduction was blocked after quercetin administration; in
this study, we showed that a similar ﬁnding was observed in
erythrocytes [3, 6, 30].
In summary, our data indicate that quercetin maintains
the antioxidant defense system and reduces systemic oxida-
tive damage, ductular proliferation, and ﬁbrosis in biliary
obstructed rats. Evaluation of blood during oxidative stress
facilitates the monitoring of treatments and the evolution
of disease. In this study, we were able to verify the same
oxidative alterations reported previously by our group using
blood samples instead of tissue homogenates, which were
usedinpreviousstudiestoevaluateoxidativestressonbiliary
cirrhosis [5, 13].
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